Intestinal inflammation influences α-MSH reactive autoantibodies: Relevance to food intake and body weight

Psychoneuroendocrinology

Volumn 37, Issue 1, 2012, Pages 94-106

  Coquerel, Quentin ^a   Sinno, Maria Hamze ^a   Boukhettala, Nabile ^a   Coëffier, Moïse ^a   Terashi, Mutsumi ^a   Bole Feysot, Christine ^a   Breuillé, Denis ^b   Déchelotte, Pierre ^a   Fetissov, Sergueï O ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Autoantibodies; Body weight; Brain; Cancer chemotherapy; Food intake; Hypothalamus; Intestinal inflammation; Neuropeptides; Peptide hormones

Indexed keywords

ALPHA INTERMEDIN; ALPHA INTERMEDIN ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; BODY WEIGHT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; ENTERITIS; FOOD INTAKE; HORMONE BLOOD LEVEL; HUMORAL IMMUNITY; MALE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; REFEEDING;

ALPHA-MSH; ANIMALS; ANOREXIA; AUTOANTIBODIES; BODY WEIGHT; DISEASE MODELS, ANIMAL; DRINKING; EATING; HUMANS; IMMUNOGLOBULIN G; MALE; METHOTREXATE; MUCOSITIS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 83055181530     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.05.008     Document Type: Article

References (45)

1. Adams J.C. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J. Histochem. Cytochem. 1992, 40:1457-1463.
2. Bertolini A., Tacchi R., Vergoni A.V. Brain effects of melanocortins. Pharm. Res. 2009, 59:13-47.
3. Blijlevens N.M. Implications of treatment-induced mucosal barrier injury. Curr. Opin. Oncol. 2005, 17:605-610.
4. Boateng A.A., Sriram K., Meguid M.M., Crook M. Refeeding syndrome: treatment considerations based on collective analysis of literature case reports. Nutrition 2010, 26:156-167.
5. Bouskra D., Brézillon C., Bérard M., Werts C., Varona R., Boneca I.G., Eberl G. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456:507-510.
6. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.F., Gibson G.R., Casteilla L., Delzenne N.M., Alessi M.C., Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
7. Chaki S., Okuyama S. Involvement of melanocortin-4 receptor in anxiety and depression. Peptides 2005, 26:1952-1964.
8. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat. Neurosci. 2005, 8:571-578.
9. Cone R.D. Studies on the physiological functions of the melanocortin system. Endocr. Rev. 2006, 27:736-749.
10. Corcos M., Guilbaud O., Paterniti S., Moussa M., Chambry J., Chaouat G., Consoli S.M., Jeammet P. Involvement of cytokines in eating disorders: a critical review of the human literature. Psychoneuroendocrinology 2003, 28:229-249.
11. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
12. Déchelotte P., Grigioni S., Fetissov S. Conséquences digestives de l'anorexie mentale. Nutr. Clin. Métab. 2007, 21:166-171.
13. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997, 385:165-168.
14. Fetissov S.O., Déchelotte P. The putative role of neuropeptide autoantibodies in anorexia nervosa. Curr. Opin. Clin. Nutr. Metab. 2008, 11:428-434.
15. Fetissov S.O., Hallman J., Oreland L., afKlinteberg B., Grenbäck E., Hulting A.L., Hökfelt T. Autoantibodies against α-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:17155-17160.
16. Fetissov S.O., Hamze Sinno M., Coëffier M., Bole-Feysot C., Ducrotté P., Hökfelt T., Déchelotte P. Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora. Nutrition 2008, 24:348-359.
17. Fetissov S.O., Hamze Sinno M., Coquerel Q., Do Rego J.C., Coëffier M., Gilbert D., Hökfelt T., Déchelotte P. Emerging role of autoantibodies against appetite-regulating neuropeptides in eating disorders. Nutrition 2008, 24:854-859.
18. Fetissov S.O., Harro J., Jaanisk M., Järv A., Podar I., Allik J., Nilsson I., Sakthivel P., Lefvert A.K., Hökfelt T. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:14865-14870.
19. Fetissov S.O., Thornton S.N. Hypovolemia-induced obesity and diabetes. Metabolism 2009, 58:1678-11678.
20. Garcia F.D., Coquerel Q., Kiive E., Déchelotte P., Harro J., Fetissov S.O. Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2010, 35:118-125.
21. Hamilton B.S., Doods H.N. Chronic application of MTII in a rat model of obesity results in sustained weight loss. Obes. Res. 2002, 10:182-187.
22. Hamze Sinno M., Coquerel Q., Boukhettala N., Coëffier M., Gallas S., Terashi M., Ibrahim A., Breuillé D., Déchelotte P., Fetissov S.O. Chemotherapy-induced anorexia is accompanied by activation of brain pathways signaling dehydration. Physiol. Behav. 2010, 101:639-648.
23. Hamze Sinno M., Do Rego J.C., Coëffier M., Bole-Feysot C., Ducrotte P., Gilbert D., Tron F., Costentin J., Hökfelt T., Déchelotte P., Fetissov S.O. Regulation of feeding and anxiety by α-MSH reactive autoantibodies. Psychoneuroendocrinology 2009, 34:140-149.
24. Harris J.I., Lerner A.B. Amino-acid sequence of the alpha-melanocyte-stimulating hormone. Nature 1957, 179:1346-1347.
25. Henry B.A., Cowley M.A., Clarke S.D., Leury B., Clarke I.J. Direct effects of alpha-melanocyte-stimulating hormone on energy expenditure in skeletal muscle. The 7th Int. Congr. Neuroendocrinol. 2010, 138.
26. Hillebrand J.J., de Wied D., Adan R.A. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 2002, 23:2283-2306.
27. Imai Y., Ibata I., Ito D., Ohsawa K., Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem. Biophys. Res. Commun. 1996, 224:855-862.
28. Jarillo-Luna A., Rivera-Aguilar V., Garfias H.R., Lara-Padilla E., Kormanovsky A., Campos-Rodríguez R. Effect of repeated restraint stress on the levels of intestinal IgA in mice. Psychoneuroendocrinology 2007, 32:681-692.
29. Kastin A.J., Pan W. Concepts for biologically active peptides. Curr. Pharm. Des. 2010, 16:3390-3400.
30. Kastin A.J., Redding T.W., Hall R., Besser G.M., Schally A.V. Lipid mobilizing hormones of the hypothalamus and pituitary. Pharmacol. Biochem. Behav. 1975, 3:121-126.
31. Konsman J.P., Veeneman J., Combe C., Poole S., Luheshi G.N., Dantzer R. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur. J. Neurosci. 2008, 28:2499-2510.
32. Leblond J., Le Pessot F., Hubert-Buron A., Duclos C., Vuichoud J., Faure M., Breuille D., Déchelotte P., Coëffier M. Chemotherapy-induced mucositis is associated with changes in proteolytic pathways. Exp. Biol. Med. (Maywood) 2008, 233:219-228.
33. Lo Russo L., Campisi G., Di Fede O., Di Liberto C., Panzarella V., Lo Muzio L. Oral manifestations of eating disorders: a critical review. Oral. Dis. 2008, 14:479-484.
34. Marks H.L., Washburn K.W. The relationship of altered water/feed intake ratios on growth and abdominal fat in commercial broilers. Poult. Sci. 1983, 62:263-272.
35. McClain C.J., Humphries L.L., Hill K.K., Nickl N.J. Gastrointestinal and nutritional aspects of eating disorders. J. Am. Coll. Nutr. 1993, 12:466-474.
36. Nilsson I., Lindfors C., Fetissov S.O., Hökfelt T., Johansen J.E. Aberrant agouti-related protein system in the hypothalamus of the anx/anx mouse is associated with activation of microglia. J. Comp. Neurol. 2008, 507:1128-1140.
37. Nilsson I.A., Thams S., Lindfors C., Bergstrand A., Cullheim S., Hökfelt T., Johansen J.E. Evidence of hypothalamic degeneration in the anorectic anx/anx mouse. Glia 2010, 59:45-57.
38. Pierroz D.D., Ziotopoulou M., Ungsunan L., Moschos S., Flier J.S., Mantzoros C.S. Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity. Diabetes 2002, 51:1337-1345.
39. Sekirov I., Russell S.L., Antunes L.C.M., Finlay B.B. Gut microbiota in health and disease. Physiol. Rev. 2010, 90:859-904.
40. Song C.K., Vaughan C.H., Keen-Rhinehart E., Harris R.B., Richard D., Bartness T.J. Melanocortin-4 receptor mRNA expressed in sympathetic outflow neurons to brown adipose tissue: neuroanatomical and functional evidence. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R417-428.
41. Stookey J.D., Constant F., Popkin B.M., Gardner C.D. Drinking water is associated with weight loss in overweight dieting women independent of diet and activity. Obesity 2008, 16:2481-2488.
42. Terashi M., Asakawa A., Harada T., Ushikai M., Coquerel Q., Sinno M.H., Déchelotte P., Inui A., Fetissov S.O. Ghrelin reactive autoantibodies in restrictive anorexia nervosa. Nutrition 2011, 27:407-413.
43. Trivedi P., Jiang M., Tamvakopoulos C.C., Shen X., Yu H., Mock S., Fenyk-Melody J., Van der Ploeg L.H.T., Guan X.-M. Exploring the site of anorectic action of peripherally administered synthetic melanocortin peptide MT-II in rats. Brain Res. 2003, 977:221-230.
44. Vincenzi B., O'Toole J., Lask B. PANDAS and anorexia nervosa-a spotters' guide: suggestions for medical assessment. Eur. Eat. Dis. Rev. 2010, 18:116-123.
45. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., Tsui H., Wu P., Davidson M.G., Alonso M.N., Leong H.X., Glassford A., Caimol M., Kenkel J.A., Tedder T.F., McLaughlin T., Miklos D.B., Dosch H.M., Engleman E.G. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17:610-617.